NCT03183050View on ClinicalTrials.gov

MEND 2: Making Treatment Decisions Using Genomic Testing

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

June 2, 2017

Primary Completion Date

January 14, 2019

Study Completion Date

January 14, 2019

Conditions
Breast Cancer Female
Interventions
BEHAVIORAL

Question Prompt List

Patients receive a booklet that contains questions regarding their diagnosis, testing and treatment.

Trial Locations (2)

20007

Medstar Cancer Network, Washington D.C.

33612

H. Lee Moffitt Cancer Center, Tampa

All Listed Sponsors
collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

collaborator

Barbara Ann Karmanos Cancer Institute

OTHER

lead

Georgetown University

OTHER

NCT03183050 - MEND 2: Making Treatment Decisions Using Genomic Testing | Biotech Hunter | Biotech Hunter